Cargando…

Hospital Variation in Time to Endovascular Treatment for Ischemic Stroke: What Is the Optimal Target for Improvement?

BACKGROUND: Time to reperfusion in patients with ischemic stroke is strongly associated with functional outcome and may differ between hospitals and between patients within hospitals. Improvement in time to reperfusion can be guided by between‐hospital and within‐hospital comparisons and requires in...

Descripción completa

Detalles Bibliográficos
Autores principales: den Hartog, Sanne J., Lingsma, Hester F., van Doormaal, Pieter‐Jan, Hofmeijer, Jeannette, Yo, Lonneke S. F., Majoie, Charles B. L. M., Dippel, Diederik W. J., van der Lugt, Aad, Roozenbeek, Bob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075196/
https://www.ncbi.nlm.nih.gov/pubmed/34927469
http://dx.doi.org/10.1161/JAHA.121.022192
_version_ 1784701626768949248
author den Hartog, Sanne J.
Lingsma, Hester F.
van Doormaal, Pieter‐Jan
Hofmeijer, Jeannette
Yo, Lonneke S. F.
Majoie, Charles B. L. M.
Dippel, Diederik W. J.
van der Lugt, Aad
Roozenbeek, Bob
author_facet den Hartog, Sanne J.
Lingsma, Hester F.
van Doormaal, Pieter‐Jan
Hofmeijer, Jeannette
Yo, Lonneke S. F.
Majoie, Charles B. L. M.
Dippel, Diederik W. J.
van der Lugt, Aad
Roozenbeek, Bob
author_sort den Hartog, Sanne J.
collection PubMed
description BACKGROUND: Time to reperfusion in patients with ischemic stroke is strongly associated with functional outcome and may differ between hospitals and between patients within hospitals. Improvement in time to reperfusion can be guided by between‐hospital and within‐hospital comparisons and requires insight in specific targets for improvement. We aimed to quantify the variation in door‐to‐reperfusion time between and within Dutch intervention hospitals and to assess the contribution of different time intervals to this variation. METHODS AND RESULTS: We used data from the MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) Registry. The door‐to‐reperfusion time was subdivided into time intervals, separately for direct patients (door‐to‐computed tomography, computed tomography‐to‐computed tomography angiography [CTA], CTA‐to‐groin, and groin‐to‐reperfusion times) and for transferred patients (door‐to‐groin and groin‐to‐reperfusion times). We used linear mixed models to distinguish the variation in door‐to‐reperfusion time between hospitals and between patients. The proportional change in variance was used to estimate the amount of variance explained by each time interval. We included 2855 patients of 17 hospitals providing endovascular treatment. Of these patients, 44% arrived directly at an endovascular treatment hospital. The between‐hospital variation in door‐to‐reperfusion time was 9%, and the within‐hospital variation was 91%. The contribution of case‐mix variables on the variation in door‐to‐reperfusion time was marginal (2%–7%). Of the between‐hospital variation, CTA‐to‐groin time explained 83%, whereas groin‐to‐reperfusion time explained 15%. Within‐hospital variation was mostly explained by CTA‐to‐groin time (33%) and groin‐to‐reperfusion time (42%). Similar results were found for transferred patients. CONCLUSIONS: Door‐to‐reperfusion time varies between, but even more within, hospitals providing endovascular treatment for ischemic stroke. Quality of stroke care improvements should not only be guided by between‐hospital comparisons, but also aim to reduce variation between patients within a hospital, and should specifically focus on CTA‐to‐groin time and groin‐to‐reperfusion time.
format Online
Article
Text
id pubmed-9075196
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90751962022-05-10 Hospital Variation in Time to Endovascular Treatment for Ischemic Stroke: What Is the Optimal Target for Improvement? den Hartog, Sanne J. Lingsma, Hester F. van Doormaal, Pieter‐Jan Hofmeijer, Jeannette Yo, Lonneke S. F. Majoie, Charles B. L. M. Dippel, Diederik W. J. van der Lugt, Aad Roozenbeek, Bob J Am Heart Assoc Original Research BACKGROUND: Time to reperfusion in patients with ischemic stroke is strongly associated with functional outcome and may differ between hospitals and between patients within hospitals. Improvement in time to reperfusion can be guided by between‐hospital and within‐hospital comparisons and requires insight in specific targets for improvement. We aimed to quantify the variation in door‐to‐reperfusion time between and within Dutch intervention hospitals and to assess the contribution of different time intervals to this variation. METHODS AND RESULTS: We used data from the MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) Registry. The door‐to‐reperfusion time was subdivided into time intervals, separately for direct patients (door‐to‐computed tomography, computed tomography‐to‐computed tomography angiography [CTA], CTA‐to‐groin, and groin‐to‐reperfusion times) and for transferred patients (door‐to‐groin and groin‐to‐reperfusion times). We used linear mixed models to distinguish the variation in door‐to‐reperfusion time between hospitals and between patients. The proportional change in variance was used to estimate the amount of variance explained by each time interval. We included 2855 patients of 17 hospitals providing endovascular treatment. Of these patients, 44% arrived directly at an endovascular treatment hospital. The between‐hospital variation in door‐to‐reperfusion time was 9%, and the within‐hospital variation was 91%. The contribution of case‐mix variables on the variation in door‐to‐reperfusion time was marginal (2%–7%). Of the between‐hospital variation, CTA‐to‐groin time explained 83%, whereas groin‐to‐reperfusion time explained 15%. Within‐hospital variation was mostly explained by CTA‐to‐groin time (33%) and groin‐to‐reperfusion time (42%). Similar results were found for transferred patients. CONCLUSIONS: Door‐to‐reperfusion time varies between, but even more within, hospitals providing endovascular treatment for ischemic stroke. Quality of stroke care improvements should not only be guided by between‐hospital comparisons, but also aim to reduce variation between patients within a hospital, and should specifically focus on CTA‐to‐groin time and groin‐to‐reperfusion time. John Wiley and Sons Inc. 2021-12-20 /pmc/articles/PMC9075196/ /pubmed/34927469 http://dx.doi.org/10.1161/JAHA.121.022192 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
den Hartog, Sanne J.
Lingsma, Hester F.
van Doormaal, Pieter‐Jan
Hofmeijer, Jeannette
Yo, Lonneke S. F.
Majoie, Charles B. L. M.
Dippel, Diederik W. J.
van der Lugt, Aad
Roozenbeek, Bob
Hospital Variation in Time to Endovascular Treatment for Ischemic Stroke: What Is the Optimal Target for Improvement?
title Hospital Variation in Time to Endovascular Treatment for Ischemic Stroke: What Is the Optimal Target for Improvement?
title_full Hospital Variation in Time to Endovascular Treatment for Ischemic Stroke: What Is the Optimal Target for Improvement?
title_fullStr Hospital Variation in Time to Endovascular Treatment for Ischemic Stroke: What Is the Optimal Target for Improvement?
title_full_unstemmed Hospital Variation in Time to Endovascular Treatment for Ischemic Stroke: What Is the Optimal Target for Improvement?
title_short Hospital Variation in Time to Endovascular Treatment for Ischemic Stroke: What Is the Optimal Target for Improvement?
title_sort hospital variation in time to endovascular treatment for ischemic stroke: what is the optimal target for improvement?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075196/
https://www.ncbi.nlm.nih.gov/pubmed/34927469
http://dx.doi.org/10.1161/JAHA.121.022192
work_keys_str_mv AT denhartogsannej hospitalvariationintimetoendovasculartreatmentforischemicstrokewhatistheoptimaltargetforimprovement
AT lingsmahesterf hospitalvariationintimetoendovasculartreatmentforischemicstrokewhatistheoptimaltargetforimprovement
AT vandoormaalpieterjan hospitalvariationintimetoendovasculartreatmentforischemicstrokewhatistheoptimaltargetforimprovement
AT hofmeijerjeannette hospitalvariationintimetoendovasculartreatmentforischemicstrokewhatistheoptimaltargetforimprovement
AT yolonnekesf hospitalvariationintimetoendovasculartreatmentforischemicstrokewhatistheoptimaltargetforimprovement
AT majoiecharlesblm hospitalvariationintimetoendovasculartreatmentforischemicstrokewhatistheoptimaltargetforimprovement
AT dippeldiederikwj hospitalvariationintimetoendovasculartreatmentforischemicstrokewhatistheoptimaltargetforimprovement
AT vanderlugtaad hospitalvariationintimetoendovasculartreatmentforischemicstrokewhatistheoptimaltargetforimprovement
AT roozenbeekbob hospitalvariationintimetoendovasculartreatmentforischemicstrokewhatistheoptimaltargetforimprovement
AT hospitalvariationintimetoendovasculartreatmentforischemicstrokewhatistheoptimaltargetforimprovement